Clinical Trials Logo

Filter by:
NCT ID: NCT04364022 Completed - Clinical trials for Prevention of COVID-19

Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland

COPEP
Start date: April 23, 2020
Phase: Phase 3
Study type: Interventional

A study to assess, in a two-arm open-label cluster randomized clinical trial, the efficacy of a 5-day course of LPV/r treatment in preventing COVID-19 in asymptomatic individuals exposed to a SARS-CoV-2 documented index patient, compared to surveillance alone.

NCT ID: NCT04363918 Completed - Clinical trials for Erectile Dysfunction

The Use of Bioelectrical Stimulation in the Treatment of Erectile Dysfunction

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Erectile dysfunction (ED), as defined by the International Consultation on Sexual Medicine, is the consistent and recurrent inability to acquire or sustain an erection of sufficient rigidity and duration to engage in satisfactory sexual intercourse. In the search for other approaches to treat ED the use of bioelectrical stimulation (BES) has been successfully introduced and applied in clinical studies. In the search for other approaches to treat ED the use of bioelectrical stimulation (BES) has been successfully introduced and applied in clinical studies.

NCT ID: NCT04362397 Completed - Attention Clinical Trials

FoCo: Evaluating a Training to Increase Attention and Awareness of Healthcare Professionals

FoCo
Start date: August 20, 2019
Phase: N/A
Study type: Interventional

Introduction: A significant increase in the risk of injury and illness at work has been associated with fatigue, stress, haste, distraction, emergency situations, excessive noise, complex procedures and anger among other factors. Most of these factors are related to the lack of attention to work in progress, which can be improved by training attention and awareness during daily activities, as it would encourage a resumption of focus on the task at hand and the possible risks associated with it. . The primary objective of this project is to evaluate the effects of training to increase attention and awareness for daily activities - FoCo - outlined for healthcare professionals in their work schedule. Method: Health professionals from 18 to 60 years of age, of both sexes, will participate in the study, working in 3 units, one in the care of patients in a Emergency Care Unit (UPA), in an Elderly Residential and in a Center. Intensive Care (ICU). In the UPA will be included 25 professionals in group A and 25 in group B; In the Residential of Elderly, 40 professionals will be included in group A and 40 professionals in group B; In the ICU will be included 30 professionals in group A and 30 in group B. They will be randomized in both groups. Group A will receive training in the FoCo program and group B will be a waiting group. After a period of one month, group B will receive training in FoCo and group A will be instructed to continue on their own to apply FoCo in their daily lives (Fig.1). Participants will be evaluated before, after one month and after two months. Expected Outcomes: After training, an increase in mindful, attention and awareness scale, self-compassion scale, positive affect, speed of digit and symbol test is expected. It is also expected to reduce negative affects, perceived stress and an increased perception of possible incidents.

NCT ID: NCT04362137 Completed - Clinical trials for Cytokine Storm (Covid-19)

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

RUXCOVID
Start date: May 2, 2020
Phase: Phase 3
Study type: Interventional

This was a randomized, double-blind, placebo-controlled, 29-day, multicenter study to assess the efficacy and safety of ruxolitinib + standard-of-care (SoC) therapy, compared with placebo + SoC therapy, in patients aged ≥12 years with COVID-19 disease.

NCT ID: NCT04361006 Completed - Cardiac Arrhythmias Clinical Trials

Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways

Start date: October 1, 2018
Phase: N/A
Study type: Interventional

A randomized pilot study to evaluate safety and efficacy endpoints for treatment of para-hisian accessory pathways according to two different strategies of lesion formation. These patients will be divided into 2 groups with different strategies of treatment: group 1 treated with radiofrequency (RF) ablation, group 2 with cryotherapy (CRYO). The primary outcome will be the recurrence rate of accessory pathway conduction after one year of follow-up. Secondary endpoints will be immediate success and rate of permanent atrioventricular (AV) block.

NCT ID: NCT04359810 Completed - Clinical trials for SARS-CoV-2 Infection

Plasma Therapy of COVID-19 in Severely Ill Patients

Start date: April 21, 2020
Phase: Phase 2
Study type: Interventional

This randomized blinded multi-center phase 2 trial will assess the efficacy and safety of anti-SARS-CoV-2 convalescent plasma among adults with severe COVID-19. Adults ≥18 years of age may participate. A total of 219 eligible subjects will be randomized in a 2:1 ratio to receive either high-titer anti-SARS-CoV-2 plasma or non-convalescent fresh frozen plasma (control plasma).

NCT ID: NCT04356911 Completed - Dentin Sensitivity Clinical Trials

The Strontium Chloride Associated With Photobiomodulation in the Control of Post-bleaching Sensitivity

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

This study investigated the effects of the association of strontium chloride with photobiomodulation on the dental bleaching process, testing the hypothesis that they may control dental sensitivity post-bleaching teeth.

NCT ID: NCT04356703 Completed - Myelomeningocele Clinical Trials

Fetoscopic Open Spina Bifida Repair Using the SAFER Technique

Start date: April 1, 2017
Phase:
Study type: Observational

Children submitted to fetoscopic in utero myelomeningocele repair using the SAFER (Skin-over-biocellulose for Anternatal FEtoscopic Repair) technique will evaluate at 30 months or more, regarding ambulation, neurodevelopment, urinary and fecal status.

NCT ID: NCT04354259 Completed - Covid-19 Clinical Trials

Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19

ILIAD
Start date: May 13, 2020
Phase: Phase 2
Study type: Interventional

Interferon lambda is one of the main arms of the innate antiviral immune response and is critical for controlling respiratory viral infections in mice. Interferon lambda has a better side effect profile than other interferons because of the limited tissue distribution of its receptor. Peginterferon lambda is a long-acting form that has been studied extensively in human trials in viral hepatitis, confirming its safety. We propose to evaluate peginterferon-lambda in ambulatory and hospitalized patients with mild to moderate COVID-19.

NCT ID: NCT04352543 Completed - Aging Clinical Trials

Active Video Game on Metabolic, Cardiovascular, and Psychological Metrics in Older Adults

Start date: July 20, 2020
Phase: N/A
Study type: Interventional

The Xbox Kinect seems to be a good alternative for the older adults to perform physical activities at times that are typically associated with sedentary behaviors. The Xbox Kinect active video game has been used in various parts of the world as entertainment. The study of metabolic, cardiovascular and psychological responses during these activities may bring relevant information regarding the intensity of the exercises and, consequently, about the possibility of using these games to maintain and / or improve the cardiorespiratory fitness of the older adults. In addition, the present study may clarify the responses of activities on Xbox Kinect in elderly people with anxiety and depression symptoms. Will be selected 100 older adults. All volunteers will initially perform assessments of resting metabolic rate, cardiorespiratory fitness, functional tests, as well as subjective assessments of physical activity level, anxiety and mood. Subsequently, they will perform activities with body movements on the Xbox Kinect, which will be compared with sedentary behavior activity (TV / Movie). All activities will be monitored by means of a gas analyzer, which will record information about the behavior of energy expenditure, resting heart rate and activity. In addition, assessments of perception of effort and fun during activities will be made through subjective scales. The effects of Xbox Kinect activity on anxiety symptoms and mood will also be assessed.